Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Stuart Naylor"'
Autor:
Paul E. Sladen, Arifa Naeem, Toyin Adefila-Ideozu, Tijmen Vermeule, Sophie L. Busson, Michel Michaelides, Stuart Naylor, Alexandria Forbes, Amelia Lane, Anastasios Georgiadis
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 3, p 1839 (2024)
Variants within the Retinitis Pigmentosa GTPase regulator (RPGR) gene are the predominant cause of X-Linked Retinitis Pigmentosa (XLRP), a common and severe form of inherited retinal disease. XLRP is characterised by the progressive degeneration and
Externí odkaz:
https://doaj.org/article/9518485a2f5c4d47a9131c00073d4aaf
Publikováno v:
Nordina: Nordic Studies in Science Education, Vol 4, Iss 2 (2012)
The PUPPETS Project set out to determine whether the use of hand-held puppets would help teachers change the nature of their whole class discourse to enhance children’s talk and engagement in primary science lessons. The research provided evidence
Externí odkaz:
https://doaj.org/article/0b5708a710124502b8b7d21a8a3ff8a3
Everybody seems to be talking about assessment for learning. This book shows how to do it. Using a highly creative approach it explains in detail how assessment, thinking and learning can be integrated in science lessons. More than 30 different asses
Autor:
Michel Michaelides, Nashila Hirji, Sui Chien Wong, Cagri G. Besirli, Serena Zaman, Neruban Kumaran, Anastasios Georgiadis, Alexander J. Smith, Caterina Ripamonti, Irene Gottlob, Anthony G. Robson, Alberta Thiadens, Robert H. Henderson, Penny Fleck, Eddy Anglade, Xiangwen Dong, George Capuano, Wentao Lu, Pamela Berry, Thomas Kane, Stuart Naylor, Michalis Georgiou, Angelos Kalitzeos, Robin R. Ali, Alexandria Forbes, James Bainbridge
Publikováno v:
American Journal of Ophthalmology.
Autor:
Anastasios Georgiadis, Alexander J. Smith, Michel Michaelides, Stuart Naylor, Alexandria Forbes
Publikováno v:
Expert Opinion on Emerging Drugs. 27:445-447
Autor:
Tahreem A. Mir, Peter A. Campochiaro, Elliott H. Sohn, Andreas K. Lauer, Michelle Kelleher, Stuart Naylor, Kyriacos A. Mitrophanous, Scott Ellis, Matthew C. Anderton, Richard Harrop
Publikováno v:
Human Gene Therapy. 28:99-111
Neovascular age-related macular degeneration (NVAMD) is a prevalent cause of vision loss. Intraocular injections of VEGF-neutralizing proteins provide benefit, but many patients require frequent injections for a prolonged period. Benefits are often l
Autor:
Philip C. Buttery, Richard Harrop, Helene Lepetit, Claire Thiriez, Xavier Drouot, G. Scott Ralph, Jean Pascal Lefaucheur, Cherry Lucas, Philippe Le Corvoisier, Pippa A Radcliffe, Philippe Hantraye, Patrice Dolphin, Pierre Brugières, Hirokazu Iwamuro, Sarah L Mason, Olivier Rascol, Gilles Fénelon, David P. Breen, Inanna Gabriel, Sarah Deeley, Michelle Kelleher, Sonia Lavisse, Kou Abhay, Aurélie Kas, Stuart Naylor, Roger A. Barker, Jean Marc Gurruchaga, Pierre Cesaro, Natalie Valle Guzman, Stéphane Palfi, Colin Watts, Kyriacos A. Mitrophanous, Nicholas D. Mazarakis, Bijan Ghaleh, James Miskin, Philippe Remy, Naoki Tani, Susan M. Kingsman
Publikováno v:
The Lancet. 383:1138-1146
Summary Background Parkinson's disease is typically treated with oral dopamine replacement therapies; however, long-term treatment leads to motor complications and, occasionally, impulse control disorders caused by intermittent stimulation of dopamin
Publikováno v:
Journal American Society of Mining and Reclamation. 2012:346-358
Coal combustion byproducts (CCBs) have potential as structural fill and capping materials in abandoned mine land (AML) reclamation because of their acid-neutralization capacity. However, the potential for these materials to leach constituents of pote
Autor:
Richard Harrop, Stuart Naylor, Michelle Kelleher, Peter Treasure, Gemma Bolton, William Shingler, Jackie de Belin
Publikováno v:
Cancer Immunology, Immunotherapy. 61:2283-2294
Cancer vaccines such as MVA-5T4 (TroVax(®)) must induce an efficacious immune response to deliver therapeutic benefit. The identification of biomarkers that impact on the clinical and/or immunological efficacy of cancer vaccines is required in order